INSCX
Price
$20.86
Change
+$0.67 (+3.32%)
Updated
May 12 closing price
Net Assets
15.4M
RGAHX
Price
$74.34
Change
+$2.72 (+3.80%)
Updated
May 12 closing price
Net Assets
285.48B
Ad is loading...

INSCX vs RGAHX

Header iconINSCX vs RGAHX Comparison
Open Charts INSCX vs RGAHXBanner chart's image
Catalyst Insider Buying C
Price$20.86
Change+$0.67 (+3.32%)
VolumeN/A
Net Assets15.4M
American Funds Growth Fund of Amer R5E
Price$74.34
Change+$2.72 (+3.80%)
VolumeN/A
Net Assets285.48B
INSCX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
INSCX vs. RGAHX commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSCX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. INSCX (15.4M). RGAHX pays higher dividends than INSCX: RGAHX (0.54) vs INSCX (0.00). INSCX was incepted earlier than RGAHX: INSCX (14 years) vs RGAHX (9 years). INSCX (3.02) is less costly to investors than RGAHX (0.44). INSCX is a more actively managed with annual turnover of: 183.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than INSCX: RGAHX (250) vs INSCX (2500). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. INSCX (2.64). RGAHX return over 5 years is better than : 44.87 vs. INSCX (19.26).
INSCXRGAHXINSCX / RGAHX
Total Expense Ratio2.280.44518%
Annual Report Gross Expense Ratio3.020.44686%
Fund Existence14 years9 years-
Gain YTD2.748-2.478-111%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.4M285B0%
Annual Yield % from dividends0.000.54-
Returns for 1 year2.643.2581%
Returns for 3 years89.0433.40267%
Returns for 5 years19.2644.8743%
Returns for 10 years28.19N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics